NovaBay Pharmaceuticals is undergoing a complete strategic transformation, abandoning its healthcare identity to become Stablecoin Development Corporation. The company is also changing its stock ticker from NBY to SDEV, signaling a full departure from its previous business focus. The move follows a $134 million private placement that has provided the capital needed to pursue its new direction.
The proceeds from the private placement are being deployed to build a substantial position in SKY, the governance token of the Sky protocol. The company currently holds approximately 2.06 billion SKY tokens, representing a significant commitment to the crypto asset. This accumulation marks the centerpiece of the firm’s newly adopted business strategy.
Beyond simply holding the tokens, the company has moved to generate returns on its SKY position through staking. Staking allows token holders to earn rewards by participating in the governance and operation of the underlying protocol. The firm reports having earned around 26.6 million SKY tokens through this activity so far.
The rebranding reflects a broader trend of publicly listed companies pivoting toward digital assets and blockchain-related businesses. By adopting the Stablecoin Development Corporation name, the firm signals its intention to position itself within the growing stablecoin sector. The Sky protocol itself is associated with stablecoin infrastructure, aligning with the company’s stated new focus.
The transition represents a notable shift for a company that previously operated in the pharmaceutical and healthcare space. With the ticker change to SDEV and a treasury anchored in SKY tokens, the firm is presenting itself as a crypto-native enterprise. Investors and market observers will be watching closely as the company moves forward with its stablecoin development ambitions.
Originally reported by CoinDesk.
